A prediction model for successful increase of adalimumab dose intervals: analysis of the pragmatic open-label randomised controlled non-inferiority LADI trial

被引：0

作者：

Van Linschoten, R. ^{[1
,2
]}

Jansen, F. ^{[3
]}

Pauwels, R. ^{[2
]}

Smits, L. ^{[3
]}

Atsma, F. ^{[4
]}

Kievit, W. ^{[5
]}

de Jong, D. ^{[3
]}

de Vries, A. ^{[2
]}

Boekema, P. ^{[6
]}

West, R.

Bodelier, A. ^{[7
]}

Gisbertz, I. ^{[8
]}

Wolfhagen, F. ^{[9
]}

Romkens, T. ^{[10
]}

Lutgens, M. ^{[11
]}

van Bodegraven, A. ^{[12
]}

Oldenburg, B. ^{[13
]}

Pierik, M. ^{[14
]}

Russel, M. ^{[15
]}

de Boer, N. ^{[16
]}

Mallant-Hent, R. ^{[17
]}

ter Borg, P. ^{[18
]}

van der Meulen-de Jong, A. ^{[19
]}

Jansen, J. ^{[20
]}

Jansen, S. ^{[21
]}

Tan, A. ^{[22
]}

van der Woude, C. J. ^{[2
]}

Hoentjen, F. ^{[23
]}

机构：

[1] Franciscus Gasthuis Vlietland, Gastroenterol & Hepatol, Rotterdam, Netherlands

[2] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands

[3] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands

[4] Radboud Univ Nijmegen, Med Ctr, IQ Healthcare, Nijmegen, Netherlands

[5] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Hlth Evidence, Nijmegen, Netherlands

[6] Maxima Med Ctr, Dept Gastroenterol & Hepatol, Eindhoven, Netherlands

[7] Amphia Hosp, Dept Gastroenterol & Hepatol, Breda, Netherlands

[8] Bernhoven Hosp, Dept Gastroenterol & Hepatol, Uden, Netherlands

[9] Albert Schweitzer Hosp, Dept Gastroenterol & Hepatol, Dordrecht, Netherlands

[10] Jeroen Bosch Hosp, Dept Gastroenterol & Hepatol, Shertogenbosch, Netherlands

[11] Elisabeth Tweesteden Hosp, Dept Gastroenterol & Hepatol, Tilburg, Netherlands

[12] Zuyderland Med Ctr, Dept Gastroenterol Geriatr Internal & Intens Care, Heerlen, Netherlands

[13] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands

[14] Maastricht Univ, Med Cter, Dept Gastroenterol & Hepatol, Maastricht, Netherlands

[15] Medisch Spectrum Twente, Dept Gastroenterol & Hepatol, Twente, Netherlands

[16] Vrije Univ Amsterdam, Amsterdam Univ, Med Ctr, Dept Gastroenterol & Hepatol,AGEM Res Inst, Amsterdam, Netherlands

[17] Flevoziekenhuis, Dept Gastroenterol & Hepatol, Almere, Netherlands

[18] Ikazia Hosp, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands

[19] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands

[20] OLVG, Dept Gastroenterol & Hepatol, Roterdam, Netherlands

[21] Reinier Graaf Gasthuis, Dept Gastroenterol & Hepatol, Delft, Netherlands

[22] Canisius Wilhelmina Hosp, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands

[23] Univ Alberta, Div Gastroenterol Dept Med, Edmonton, AB, Canada

来源：

JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P526

引用

页码：655 / 658

页数：3

共 50 条

[31] Intraoperative versus extended antimicrobial prophylaxis after gastric cancer surgery: a phase 3, open-label, randomised controlled, non-inferiority trial
Imamura, Hiroshi
Kurokawa, Yukinori
Tsujinaka, Toshimasa
Inoue, Kentaro
Kimura, Yutaka
Iijima, Shohei
Shimokawa, Toshio
Furukawa, Hiroshi
LANCET INFECTIOUS DISEASES, 2012, 12 (05): : 381 - 387
[32] Appendicectomy versus antibiotics for acute uncomplicated appendicitis in children: an open-label, international, multicentre, randomised, non-inferiority trial
St Peter, Shawn D.
Noel-MacDonnell, Janelle R.
Hall, Nigel J.
Eaton, Simon
Suominen, Janne S.
Wester, Tomas
Svensson, Jan F.
Almstrom, Markus
Muenks, E. Pete
Beaudin, Marianne
Piche, Nelson
Brindle, Mary
MacRobie, Ali
Keijzer, Richard
Lilja, Helene Engstrand
Kassa, Ann-Marie
Jancelewicz, Tim
Butter, Andreana
Davidson, Jacob
Skarsgard, Erik
Te-Lu, Yap
Nah, Shireen
Willan, Andrew R.
Pierro, Agostino
LANCET, 2025, 405 (10474): : 233 - 240
[33] Telemedical support for prehospital emergency medical service in severe emergencies: an open-label randomised non-inferiority clinical trial
Kowark, Ana
Felzen, Marc
Ziemann, Sebastian
Wied, Stephanie
Czaplik, Michael
Beckers, Stefan K.
Brokmann, Jorg C.
Hilgers, Ralf-Dieter
Rossaint, Rolf
CRITICAL CARE, 2023, 27 (01)
[34] Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial
Jacewicz, Maciej
Guenzel, Karsten
Rud, Erik
Sandbaek, Gunnar
Magheli, Ahmed
Busch, Jonas
Hinz, Stefan
Baco, Eduard
LANCET INFECTIOUS DISEASES, 2022, 22 (10): : 1465 - 1471
[35] Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial
Aujesky, Drahomir
Roy, Pierre-Marie
Verschuren, Franck
Righini, Marc
Osterwalder, Joseph
Egloff, Michael
Renaud, Bertrand
Verhamme, Peter
Stone, Roslyn A.
Legal, Catherine
Sanchez, Olivier
Pugh, Nathan A.
N'gako, Alfred
Cornuz, Jacques
Hugii, Olivier
Beer, Hans-Juerg
Perrier, Arnaud
Fine, Michael J.
Yealy, Donald M.
LANCET, 2011, 378 (9785): : 41 - 48
[36] Aspirin versus anticoagulation in cervical artery dissection (TREAT-CAD): an open-label, randomised, non-inferiority trial
Engelter, Stefan T.
Traenka, Christopher
Gensicke, Henrik
Schaedelin, Sabine A.
Luft, Andreas R.
Simonetti, Barbara Goeggel
Fischer, Urs
Michel, Patrik
Sirimarco, Gaia
Kagi, Georg
Vehoff, Jochen
Nedeltchev, Krassen
Kahles, Timo
Kellert, Lars
Rosenbaum, Sverre
von Rennenberg, Regina
Sztajzel, Roman
Leib, Stephen L.
Jung, Simon
Gralla, Jan
Bruni, Nicole
Seiffge, David
Feil, Katharina
Polymeris, Alexandros A.
Steiner, Levke
Hamann, Janne
Bonati, Leo H.
Brehm, Alex
De Marchis, Gian Marco
Peters, Nils
Stippich, Christoph
Nolte, Christian H.
Christensen, Hanne
Wegener, Susanne
Psychogios, Marios-Nikos
Arnold, Marcel
Lyrer, Philippe
LANCET NEUROLOGY, 2021, 20 (05): : 341 - 350
[37] Comparison of two schedules of two-dose priming with the ten-valent pneumococcal conjugate vaccine in Nepalese children: an open-label, randomised non-inferiority controlled trial
Kandasamy, Rama
Gurung, Meeru
Thorson, Stephen
Yu, Ly-Mee
Galal, Ushma
Voysey, Merryn
Kelly, Sarah
Wahl, Brian
Berbers, Guy
Finnegan, Kier
Ansari, Imran
Paudel, Krishna
Murdoch, David R.
O'Brien, Katherine L.
Kelly, Dominic F.
Goldblatt, David
Shrestha, Shrijana
Pollard, Andrew J.
LANCET INFECTIOUS DISEASES, 2019, 19 (02): : 156 - 164
[38] Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial
Coles, Charlotte E.
Haviland, Joanne S.
Kirby, Anna M.
Griffin, Clare L.
Sydenham, Mark A.
Titley, Jenny C.
Bhattacharya, Indrani
Brunt, A. Murray
Chan, H. Y. Charlie
Donovan, Ellen M.
Eaton, David J.
Emson, Marie
Hopwood, Penny
Jefford, Monica L.
Lightowlers, Sara, V
Sawyer, Elinor J.
Syndikus, Isabel
Tsang, Yat M.
Twyman, Nicola, I
Yarnold, John R.
Bliss, Judith M.
LANCET, 2023, 401 (10394): : 2124 - 2137
[39] Appendectomy versus non-operative treatment for acute uncomplicated appendicitis in children: study protocol for a multicentre, open-label, non-inferiority, randomised controlled trial
Hall, Nigel J.
Eaton, Simon
Abbo, Olivier
Arnaud, Alexis P.
Beaudin, Marianne
Brindle, Mary
Butter, Andreana
Davies, Dafydd
Jancelewicz, Tim
Johnson, Kathy
Keijzer, Richard
Lapidus-Krol, Eveline
Offringa, Martin
Piche, Nelson
Rintala, Risto
Skarsgard, Erik
Svensson, Jan F.
Ungar, Wendy J.
Wester, Tomas
Willan, Andrew R.
Zani, Augusto
St Peter, Shawn D.
Pierro, Agostino
BMJ PAEDIATRICS OPEN, 2017, 1 (01)
[40] Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial
Mitja, Oriol
Hays, Russell
Ipai, Anthony
Penias, Moses
Paru, Raymond
Fagaho, David
de Lazzari, Elisa
Bassat, Quique
LANCET, 2012, 379 (9813): : 342 - 347

← 1 2 3 4 5 →